Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease-Reference-Cited by-同舟云学术

Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease

Published:2018-10-24 Issue:7 Volume:54 Page:987-993
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Danylesko Ivetta,Bukauskas Adomas,Paulson Martin,Peceliunas Valdas,Gedde-Dahl d.y Tobias,Shimoni Avichai,Shouval Roni,Griskevicius Laimonas,Floisand Yngvar,Nagler Arnon

Funder

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0364-5.pdf

Reference34 articles.

1. Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C. et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2012;18:1150–63. https://doi.org/10.1016/j.bbmt.2012.04.005 .

2. Deeg HJ. How I treat refractory acute GVHD. Blood. 2007;109:4119–26. https://doi.org/10.1182/blood-2006-12-041889 .

3. Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, et al. Diagnosis and management of acute graft-versus-host disease. Br J Haematol. 2012;158:30–45. https://doi.org/10.1111/j.1365-2141.2012.09129.x .

4. Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A, et al. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transplant. 2014;49:168–73. https://doi.org/10.1038/bmt.2013.107 .

5. Ibrahim RB, Abidi MH, Cronin SM, Lum LG, Al-Kadhimi Z, Ratanatharathorn V, et al. Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2009;15:395–405. https://doi.org/10.1016/j.bbmt.2008.12.487 .

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetic modeling of vedolizumab for graft‐versus‐host disease prophylaxis in adults with allogeneic hematopoietic stem cell transplant;Pharmacology Research & Perspectives;2024-09-04

2. Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease;Frontiers in Immunology;2024-07-03

3. Corticosteroid-resistant immune-related adverse events: a systematic review;Journal for ImmunoTherapy of Cancer;2024-01

4. Vedolizumab for second-line treatment of steroid-refractory gastrointestinal late acute graft-versus-host disease;Therapeutic Advances in Hematology;2024-01

5. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease;Blood Advances;2023-09-12